Evaluation of Pantaprazol on cardiac and hepatic iron overload in patient with major and intermediate Thalassemia
Phase 2
Recruiting
- Conditions
- major and intermediate Thalasemia.Beta thalassaemia
- Registration Number
- IRCT2017042220258N40
- Lead Sponsor
- Vice Chancellor forResearch, Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with major and intermediate Thalassemia; age more than 7 years
Exclusion criteria: Drug intolerance; unwilling to participate in the study; heart failure; hepatitis; HIV
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feritin in serum. Timepoint: before and 6 months after 6 treatment. Method of measurement: Blood test.;Heart and liver iron load. Timepoint: before and 6 months after 6 treatment. Method of measurement: MRI * 2T?.
- Secondary Outcome Measures
Name Time Method